Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma

NCT04583020 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Camrelizumab
RADIATION: radiation
DRUG: Temozolomide

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]